Ayala Pharmaceuticals Inc (ADXS)
0.57
-0.08
(-11.70%)
USD |
OTCM |
Apr 18, 16:00
Ayala Pharmaceuticals Total Liabilities (Quarterly): 41.00M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 41.00M |
| September 30, 2023 | 13.22M |
| June 30, 2023 | 11.14M |
| December 31, 2022 | 8.868M |
| September 30, 2022 | 6.101M |
| June 30, 2022 | 6.661M |
| March 31, 2022 | 5.829M |
| December 31, 2021 | 6.969M |
| Date | Value |
|---|---|
| September 30, 2021 | 6.36M |
| June 30, 2021 | 5.712M |
| March 31, 2021 | 6.199M |
| December 31, 2020 | 7.43M |
| September 30, 2020 | 6.461M |
| June 30, 2020 | 6.319M |
| March 31, 2020 | 60.39M |
| December 31, 2019 | 58.97M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.712M
Minimum
Jun 2021
60.39M
Maximum
Mar 2020
16.10M
Average
6.815M
Median
Total Liabilities (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 384.09M |
| InspireMD Inc | 8.142M |
| BiomX Inc | 21.95M |
| Alpha Tau Medical Ltd | 22.91M |
| Pluri Inc | 34.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.58M |
| Shareholders Equity (Quarterly) | -24.42M |